| |
Pediatric
Academic
Societies'
Annual Meeting
|

|
|
|
|
|
|
|
|
|

Sponsoring
Organizations
Click on
the links below to visit individual websites
American
Pediatric Society
Society
for Pediatric Research
Ambulatory
Pediatric Association
Alliance
Organizations
Program
Information
Program
Committee & Contacts
Abstracts
Awards
Registration
& Housing
Exhibits
Support
and Partnerships
Future
Meetings
Past
Meetings
Pediatric
Related Links
- Contact
Information
- Mail
Address:
- Suite
B-7
3400 Research Forest Drive
- The
Woodlands, TX 77381 USA
- Telephone:
281-419-0052
- Facsimile:
281-419-0082
|
|
|
MEETING
PROGRAM BY SUBSPECIALTY/TRACK
|
|
|
|
|
Return
to Track Selection
|
|
Go
to Day-by-Day Schedule
|
|
Go
to Alliance Programs
|
|
Go
to
PAS Meeting Home
|
INTERNATIONAL
HEALTH
Saturday, May 4, 2002
12:00pm – 3:00pm
Special Interest Group
4110
International Health
Cochairs: Anna Mandalakas, amm13@po.cwru.edu,
and Cynthia Howard, choward@umaryland.edu
5:15pm – 7:15pm
Poster Session I (Author Attended)
and Opening Reception
– Behavioral Pediatrics
Sunday, May 5, 2002
1:45pm – 2:30pm
State of the Art Plenary
5590
Children as Victims of Bioterrorism: Protecting the
Fragile Host
Chairs: Phyllis Dennery,
Stanford University School of Medicine, Palo Alto, CA
and Tina Lee Cheng, Johns Hopkins University School of
Medicine, Baltimore, MD
With the recent world events
and new threats of biowarfare, what should pediatricians
know? Due to their size and physiology, children are at
higher risk of injury from bioterrorism. This session
will address the biology, clinical manifestations, and
possible preventive strategies for likely biowarfare
agents. The unique vulnerability of the child will be
addressed.
Overview
Phyllis A. Dennery, Stanford University School of
Medicine, Palo Alto, CA
Children as Victims of Bioterrorism: Protecting the
Fragile Host
Ralph D. Feigin, Baylor College of Medicine,
Houston, TX
Discussion
2:00pm
– 4:00pm
State of the Art Plenary
5701
Children as Research Subjects: Ethical and Regulatory
Issues
Chair: Myron Genel, Yale
University School of Medicine, New Haven, CT
A number of highly publicized
adverse events, including the death of two volunteers
participating in non-therapeutic research, and the
federal shutdown of research at many well-recognized
academic institutions because of inadequate compliance
with regulatory requirements have intensified scrutiny
of the protection afforded to human subjects
participating in research, including children.
Furthermore a Maryland court has recently decreed that
children cannot participate in research without the
potential for direct benefit. As a consequence there has
been increasing media attention and Congressional
concern regarding the adequacy of institutional
oversight and investigator attentiveness to established
standards and regulations. In addition, new regulations
issued under the Health Insurance Portability and
Accountability Act of l996(HIPAA) threaten the capacity
to conduct health services and outcomes research. These
issues will be addressed in the 9th annual Public Policy
Plenary Symposium in an interactive format intended to
stimulate dialogue among the members of the panel and
with the audience.
Overview
Myron Genel, Yale University School of Medicine, New
Haven, CT
Overseeing Research in Children: New Concerns and New
Regulations
Alan R. Fleischman, The New York Academy of
Medicine, New York, NY
International Health Research: Where Bioethics,
Politics and Economics Converge
Eric M. Meslin, Indiana University Center for
Bioethics, Indianapolis, IN
Compliance: What You and Your Institution Need to
Know (and Do)
Pearl O'Rourke, Partners HealthCare System, Inc.,
Boston, MA
HIPAA, Privacy & Confidentiality and Research In
Children?
Brian Kamoie, The George Washington University,
Washington, DC
Discussion
Sponsored jointly with the Public Policy Council
of the APS, AMSPDC, SPR and the Public Policy Committee
of the APA
Partially supported by an educational grant from
Columbus Children's Hospital
4:15pm – 6:15pm
Topic Symposium
5802
The Molecular Basis of Clinical Manifestations of
Infection
Chair: Philip Brunell,
NIAID, National Institutes of Health, Bethesda, MD
This symposium will explore
the molecular basis of the clinical expression of
infectious diseases. The effect of a variety of
different agents on the different organ systems of the
human body will be presented by experts in their fields.
Mycobacterial Susceptibility: What We Get and Why
Steven M. Holland, National Institute of Allergy and
Infectious Disease/NIH, Bethesda, MD
Cryptosporidium
Anthony R. Hayward, National Institute of Health,
National Center for Research Resources, Bethesda, MD
Cellular Genes That Modulate the Outcome of EBV
Infection
Jeffrey I. Cohen, National Institutes of Health,
Bethesda, MD
Host-Pathogen Interactions in Candida Infections
Margaret K. Hostetter, Yale University School of
Medicine, New Haven, CT
Sponsored jointly with the Pediatric Infectious
Diseases Society
Monday, May 6, 2002
10:15am – 12:15pm
Platform Session
6204
Underserved Populations II
Chairs: Paul L. McCarthy
and Ronald C. Samuels
1:30pm – 5:30pm
APA Presidential Plenary
6450
APA Presidential Plenary and Armstrong Lecture
Chair: Steve Ludwig
The George Armstrong
Lecture
Steven A. Schroeder
Ray E. Helfer Award for Innovation in Pediatric
Education: Measuring Medical Knowledge Competencies
Using Web-Enhanced Instruction During a Pediatric
Resident Ambulatory Block Month
Carl E. Johnson
Larry C. Hurtubise
International Health Award: Clinical Presentation,
Immediate Outcome and Prognostic Factors of Cerebral
Malaria in Children Admitted to Mulago Hospital
Richard Idro
Distinguished Career Award
Barbara Starfield
Tuesday, May 7, 2002
1:45pm – 3:45pm
Hot Topic
7702
Disaster Preparedness: Beyond 9/11
Chairs: Tina L. Cheng,
Johns Hopkins University School of Medicine, Baltimore,
MD; Danelle Laraque, Mount Sinai School of Medicine, New
York, NY; and Benard Dreyer, New York, NY
The impact of 9/11 and the
public health aftermath have affected us personally and
professionally. This session will address what the child
health professional needs to know regarding disaster
planning and preparedness. Speakers will review and
provide updates on national and regional systems for
emergency management and how those systems interact with
local public health agencies, the pediatrician's role in
the community's preparedness including what the school
system, the pediatric office and the patient should be
doing to prepare and respond, recognition and management
of chemical and biologic agents of terrorism, and the
psychological reactions to disaster and stress.
Disaster Planning and Preparedness for Child Health
Professionals
George L. Foltin, New York University School of
Medicine and Bellevue Hospital Center, New York, NY
Biologic Agents of Terrorism
Anne Fine, New York City Department of Health, New
York, NY
Chemical Agents of Terrorism
Fred Henretig, University of Pennsylvania School of
Medicine and Children's Hospital of Philadelphia,
Philadelphia, PA
Helping Children Cope with Terrorism and Disasters
David J. Schonfeld, Yale University School of
Medicine, New Haven, CT
Discussion
|
|
Copyright:
All information contained in this Website is the property
of the Pediatric Academic Societies unless otherwise noted.
Duplication of any information contained herein for
reasons other than personal use requires the expressed
written permission of PAS.
For comments or concerns
about the website, please contact webmaster@pas-meeting.org.
Last Updated: September 27, 2006
|